The FASEB Journal, Vol 3, 2194-2202, Copyright © 1989 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Inhibition of lymphocyte proliferation by antibodies to prolactin

DP Hartmann, JW Holaday and EW Bernton
Department of Pathology, Georgetown University School of Medicine, Washington, D.C. 20007.

Recent in vivo studies have shown that treatments that decrease circulating prolactin (PRL) in rodents result in significant immunosuppression. Our attempts to demonstrate corresponding direct stimulatory effects of PRL on cultured lymphocytes were unsuccessful. However, antibodies against pituitary PRL potently inhibited both murine and human lymphocyte proliferation in response to both T and B cell mitogens. Further studies using IL 2 and IL 4 responsive cell lines (CTLL-2 and HT-2) demonstrated that the same anti-PRL antibodies inhibited the proliferative response to these cytokine growth factors. Thus, antibodies to PRL appear to block an event occurring in the G1 to GS phase transition of these cell lines, which constitutively express growth factor receptors. The inhibitory activity of anti-PRL antibodies could be adsorbed by addition of purified human PRL or by immobilized PRL on an affinity column. Antibodies to other pituitary hormones were without inhibitory effect on CTLL-2 cell proliferation. Proliferation of lymphocytes in serum-free medium was also potently inhibited by anti- PRL antibodies, suggesting that antibody effects were not due to neutralization of PRL or other factors contained in culture serum supplements. We suggest from these data that a protein with homology to PRL and recognized by these anti-PRL antibodies is produced by lymphocytes and plays a critical role in their progression through the cell cycle.

This article has been cited by other articles:

				Z. Kang, G. Y. Bedecarrats, and D. Zadworny Expression Patterns of the Prolactin Receptor Gene in Chicken Lymphoid Tissues During Embryogenesis and Posthatch Period Poult. Sci., November 1, 2007; 86(11): 2404 - 2412. [Abstract] [Full Text] [PDF]

				Y. Wang, C. T. Chiu, T. Nakamura, A. M. Walker, B. Petridou, M. D. Trousdale, S. F. Hamm-Alvarez, J. E. Schechter, and A. K. Mircheff Elevated prolactin redirects secretory vesicle traffic in rabbit lacrimal acinar cells Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1122 - E1134. [Abstract] [Full Text] [PDF]

				J. Zhang, R. Sun, and Z. Tian Human Prolactin Promotes Human Secondary Immunoglobulin Response in Human/SCID Mouse Chimeras Clin. Vaccine Immunol., January 1, 2007; 14(1): 60 - 64. [Abstract] [Full Text] [PDF]

				N. Krishnan, O. Thellin, D. J. Buckley, N. D. Horseman, and A. R. Buckley Prolactin Suppresses Glucocorticoid-Induced Thymocyte Apoptosis in Vivo Endocrinology, May 1, 2003; 144(5): 2102 - 2110. [Abstract] [Full Text] [PDF]

				O. Gubbay, H. O. D. Critchley, J. M. Bowen, A. King, and H. N. Jabbour Prolactin Induces ERK Phosphorylation in Epithelial and CD56+ Natural Killer Cells of the Human Endometrium J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2329 - 2335. [Abstract] [Full Text] [PDF]

				L. A. Welniak, R. Sun, and W. J. Murphy The role of growth hormone in T-cell development and reconstitution J. Leukoc. Biol., March 1, 2002; 71(3): 381 - 387. [Abstract] [Full Text] [PDF]

				D W Montgomery Prolactin production by immune cells Lupus, October 1, 2001; 10(10): 665 - 675. [Abstract] [PDF]

				A R Buckley Prolactin, a lymphocyte growth and survival factor Lupus, October 1, 2001; 10(10): 684 - 690. [Abstract] [PDF]

				L.-y. Yu-Lee Stimulation of interferon regulatory factor-1 by prolactin Lupus, October 1, 2001; 10(10): 691 - 699. [Abstract] [PDF]

				F Blanco-Favela, K Chavez-Rueda, and A Leanos-Miranda Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus Lupus, October 1, 2001; 10(10): 757 - 761. [Abstract] [PDF]

				M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF]

				K. Dorshkind and N. D. Horseman The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency Endocr. Rev., June 1, 2000; 21(3): 292 - 312. [Abstract] [Full Text]

				C. Bos, C. Gaudichon, and D. Tome Nutritional and Physiological Criteria in the Assessment of Milk Protein Quality for Humans J. Am. Coll. Nutr., April 1, 2000; 19(90002): 191S - 205. [Abstract] [Full Text] [PDF]

				T. Iwasaka, S. Umemura, K. Kakimoto, H. Koizumi, and Y. R. Osamura Expression of Prolactin mRNA in Rat Mammary Gland During Pregnancy and Lactation J. Histochem. Cytochem., March 1, 2000; 48(3): 389 - 396. [Abstract] [Full Text]

				J. B. Kline, H. Roehrs, and C. V. Clevenger Functional Characterization of the Intermediate Isoform of the Human Prolactin Receptor J. Biol. Chem., December 10, 1999; 274(50): 35461 - 35468. [Abstract] [Full Text] [PDF]

				C. P. Castro, R. Peñalva, M. P. Pereda, U. Renner, J. M. H. M. Reul, G. K. Stalla, F. Holsboer, and E. Arzt Early Activation of Thyrotropin-Releasing-Hormone and Prolactin Plays a Critical Role during a T Cell-Dependent Immune Response Endocrinology, February 1, 1999; 140(2): 690 - 697. [Abstract] [Full Text]

				S E Walker, D Miller, D L Hill, and G R Komatireddy Prolactin, a pituitary hormone that modifies immune responses: Proceedings of the Mini-symposium on Prolactin and SLE, held at the 5th International Conference on Systemic Lupus Erythematosus, Cancun, Mexico Lupus, July 1, 1998; 7(6): 371 - 375. [PDF]

				C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice Endocr. Rev., June 1, 1998; 19(3): 225 - 268. [Abstract] [Full Text]

				W.-P. Chang, Y. Ye, and C. V. Clevenger Stoichiometric Structure-Function Analysis of the Prolactin Receptor Signaling Domain by Receptor Chimeras Mol. Cell. Biol., February 1, 1998; 18(2): 896 - 905. [Abstract] [Full Text]

				R. L. Jones, H. O. D. Critchley, J. Brooks, H. N. Jabbour, and A. S. McNeilly Localization and Temporal Expression of Prolactin Receptor in Human Endometrium J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 258 - 262. [Abstract] [Full Text]

				F. Larrea, A. Martinez-Castillo, V. Cabrera, J. Alcocer-Varela, G. Queipo, C. Carino, and D. Alarcon-Segovia A Bioactive 60-Kilodalton Prolactin Species Is Preferentially Secreted in Cultures of Mitogen-Stimulated and Nonstimulated Peripheral Blood Mononuclear Cells from Subjects with Systemic Lupus Erythematosus J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3664 - 3669. [Abstract] [Full Text] [PDF]

				C. V. Clevenger, K. Thickman, W. Ngo, W.-P. Chang, S. Takayama, and J. C. Reed Role of Bag-1 in the Survival and Proliferation of the Cytokine-Dependent Lymphocyte Lines, Ba/F3 and Nb2 Mol. Endocrinol., May 1, 1997; 11(5): 608 - 618. [Abstract] [Full Text]

				R. Clark The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function Endocr. Rev., April 1, 1997; 18(2): 157 - 179. [Abstract] [Full Text]

				C. V. Clevenger, W. Ngo, D. L. Sokol, S. M. Luger, and , A. M. Gewirtz Vav Is Necessary for Prolactin-stimulated Proliferation and Is Translocated into the Nucleus of a T-cell Line J. Biol. Chem., June 2, 1995; 270(22): 13246 - 13253. [Abstract] [Full Text] [PDF]

				R. J. Nelson and J. M. C. Blom Photoperiodic Effects on Tumor Development and Immune Function J Biol Rhythms, December 1, 1994; 9(3-4): 233 - 249. [Abstract] [PDF]

				S. E. Walker Prolactin: An Immune-Stimulating Peptide that Regulates Other Immune-Modulating Hormones Lupus, April 1, 1993; 2(2): 67 - 69. [PDF]

				C. Clevenger, S. Altmann, and M. Prystowsky Requirement of nuclear prolactin for interleukin-2--stimulated proliferation of T lymphocytes Science, July 5, 1991; 253(5015): 77 - 79. [Abstract] [PDF]